Home/Filings/3/0001213900-24-004558
3//SEC Filing

JP Bio Consulting LLC 3

Accession 0001213900-24-004558

CIK 0001840563other

Filed

Jan 17, 7:00 PM ET

Accepted

Jan 18, 4:54 PM ET

Size

3.8 KB

Accession

0001213900-24-004558

Insider Transaction Report

Form 3
Period: 2023-11-13
JP Bio Consulting LLC
DirectorCEO10% Owner
Holdings
  • Common Stock

    2,851,454

Documents

1 file

Issuer

Elevai Labs Inc.

CIK 0001840563

Entity typeother
IncorporatedCA

Related Parties

1
  • filerCIK 0002003776

Filing Metadata

Form type
3
Filed
Jan 17, 7:00 PM ET
Accepted
Jan 18, 4:54 PM ET
Size
3.8 KB